Skip to main content
Daan Gene Co., Ltd. logo

Daan Gene Co., Ltd. - Investor Relations & Filings

Listed IPO Aug 2004
Ticker · 002030 ISIN · CNE000001KP1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,196 across all filing types
Latest filing 2026-04-27 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002030 · 1 venue

About Daan Gene Co., Ltd.

https://www.daangene.com

Daan Gene Co., Ltd. specializes in the development and manufacturing of molecular diagnostic products and services. The company focuses on in vitro diagnostic technologies, particularly polymerase chain reaction (PCR) platforms. Its product portfolio includes diagnostic kits for infectious diseases, genetic screening, and oncology, alongside automated nucleic acid extraction systems and real-time PCR instruments. Daan Gene provides comprehensive solutions for clinical laboratories and public health institutions, integrating research, production, and clinical testing services. The organization emphasizes technological innovation in molecular biology to support precision medicine and disease control.

Recent filings

Filing Released Lang Actions
独立董事述职报告（范建兵）
Board/Management Information Classification · 95% confidence The document is a detailed annual performance report of an independent director for the year 2025 at Guangzhou Da An Gene Co., Ltd. It includes descriptions of the director's duties, attendance at board and shareholder meetings, committee work, communication with auditors, oversight of governance and financial reporting, and other governance-related activities. The document is not a financial report, audit report, or earnings release, but rather a management/governance-related report focusing on the independent director's role and activities. It does not announce voting results or changes in management but provides a comprehensive narrative of the director's annual duties and observations. This fits best under Board/Management Information (MANG), which covers announcements and reports related to board or senior management activities and changes. The document length (5179 characters) and content confirm it is a substantive report, not a brief announcement or certification. Therefore, the classification is MANG with high confidence.
2026-04-27 Chinese
独立董事述职报告（侯向京）
Board/Management Information Classification · 95% confidence The document is a detailed annual performance report of an independent director for the year 2025 at Guangzhou Da An Gene Co., Ltd. It includes descriptions of the director's duties, attendance at board and shareholder meetings, committee work, communication with auditors, oversight of governance and financial reporting, and other governance-related activities. The content focuses on the director's role in corporate governance, compliance with laws and regulations, and protection of shareholder interests, rather than financial results or audit opinions. There is no indication that this is a full annual report (10-K), audit report (AR), or earnings release (ER). It is not a proxy statement or voting results announcement. The document is a management/governance related report about board activities and director duties. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (4647 characters) and detailed content support this classification with high confidence.
2026-04-27 Chinese
2025年度社会责任报告
Environmental & Social Information Classification · 95% confidence The document is titled as the "2025年度社会责任报告" (2025 Annual Social Responsibility Report) of Guangzhou Da An Gene Co., Ltd. It extensively covers the company's social responsibility activities, including governance, employee rights, environmental protection, and social contributions for the year 2025. The content focuses on Environmental, Social, and Governance (ESG) factors, sustainability efforts, and corporate social responsibility initiatives rather than financial performance or regulatory filings. The length is substantial (over 12,000 characters), indicating a full report rather than a brief announcement. Therefore, the document fits the category of Environmental & Social Information (SR).
2026-04-27 Chinese
关于2026年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Guangzhou Da An Gene Co., Ltd. regarding the expected daily related party transactions for the fiscal year 2026. It includes detailed descriptions of related parties, transaction categories, amounts, pricing policies, and independent directors' opinions. The document is not a financial report like an annual or interim report, nor is it a call transcript, earnings release, or capital update. It is a regulatory announcement about related party transactions, which is a common type of regulatory filing in Chinese listed companies. The document length is about 11,757 characters, and it contains detailed disclosure information but no financial statements or management discussion of results. It is not a report publication announcement since it contains substantive content rather than just a notice of report availability. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2026-04-27 Chinese
公司章程（2026年4月）
Governance Information Classification · 100% confidence The document is titled "章程" which translates to "Articles of Association" or "Company Bylaws." It contains detailed provisions about the company's organizational structure, shareholder rights, board of directors, management, financial accounting, audit, meetings, voting procedures, and other governance-related rules. It references relevant laws and regulations such as the Company Law of the People's Republic of China, Securities Law, and guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange. The content is focused on the internal governance framework and rules of the company rather than financial results, audit opinions, or announcements. It is a governance document that sets out the company's internal rules and board structure. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content confirm it is the full governance document, not a brief announcement or summary.
2026-04-27 Chinese
关于变更经营范围并修改《公司章程》的公告
Board/Management Information Classification · 95% confidence The document is an official announcement from Guangzhou Da An Gene Co., Ltd. regarding changes to the company's business scope and amendments to the company's articles of association. It details the proposed revisions to the business scope and corresponding changes to the company charter, and states that these changes require shareholder approval and regulatory registration. The document is a formal public notice about corporate governance and operational scope changes, not a financial report, earnings release, or management discussion. It does not contain financial data or results but focuses on corporate governance and operational scope amendments. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in company governance or management-related corporate actions such as amendments to the articles of association or business scope changes.
2026-04-27 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.